Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 20, 2021

View Archived Issues

Janssen describes new dihydroorotate dehydrogenase inhibitors

New CDK7 inhibitors discovered at Lilly

Senda Biosciences identifies aryl hydrocarbon receptor antagonists

New three-prime repair exonuclease 1 inhibitors synthesized at Constellation Pharmaceuticals

Axial Therapeutics discovers Toll-like receptor 2 agonists

REST loss promotes breast cancer tumor progression

AcuraStem presents preclinical data for AS-202 in ALS

Novel CD70-directed CAR-NK cells for the treatment of CD70-positive malignancies

Researchers discover more than 1,300 genes linked to congenital heart disease

PFKFB3 targeting shows promise for treating breast cancer

DAN-311 demonstrates consistent and durable efficacy in HER2-low breast cancer models

SRSF1 is a therapeutic target for the treatment of breast cancer

Discovery of T-036, a novel brain-penetrant GCS inhibitor for the treatment of Gaucher's disease

Celularity and Sorrento Therapeutics present preclinical data for CAR19-CYNK immunotherapeutic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...